Cargando…
P13 Risk of COVID-19 Vaccine Breakthrough Infection in Fully Vaccinated Patients with Multiple Comorbid Conditions in the United States
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232695/ http://dx.doi.org/10.1016/j.jval.2022.04.019 |
| _version_ | 1784735642732724224 |
|---|---|
| author | Liu, M. Wong, A.C. McPheeters, J.T. Dixon, R. Madge, V. Basra, G. Sachdev, A. Veeranki, P. |
| author_facet | Liu, M. Wong, A.C. McPheeters, J.T. Dixon, R. Madge, V. Basra, G. Sachdev, A. Veeranki, P. |
| author_sort | Liu, M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9232695 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92326952022-06-27 P13 Risk of COVID-19 Vaccine Breakthrough Infection in Fully Vaccinated Patients with Multiple Comorbid Conditions in the United States Liu, M. Wong, A.C. McPheeters, J.T. Dixon, R. Madge, V. Basra, G. Sachdev, A. Veeranki, P. Value Health Emerging Evidence on Sars-COV2 Vaccine Utilization and Outcomes Published by Elsevier Inc. 2022-07 2022-06-25 /pmc/articles/PMC9232695/ http://dx.doi.org/10.1016/j.jval.2022.04.019 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Emerging Evidence on Sars-COV2 Vaccine Utilization and Outcomes Liu, M. Wong, A.C. McPheeters, J.T. Dixon, R. Madge, V. Basra, G. Sachdev, A. Veeranki, P. P13 Risk of COVID-19 Vaccine Breakthrough Infection in Fully Vaccinated Patients with Multiple Comorbid Conditions in the United States |
| title | P13 Risk of COVID-19 Vaccine Breakthrough Infection in Fully Vaccinated Patients with Multiple Comorbid Conditions in the United States |
| title_full | P13 Risk of COVID-19 Vaccine Breakthrough Infection in Fully Vaccinated Patients with Multiple Comorbid Conditions in the United States |
| title_fullStr | P13 Risk of COVID-19 Vaccine Breakthrough Infection in Fully Vaccinated Patients with Multiple Comorbid Conditions in the United States |
| title_full_unstemmed | P13 Risk of COVID-19 Vaccine Breakthrough Infection in Fully Vaccinated Patients with Multiple Comorbid Conditions in the United States |
| title_short | P13 Risk of COVID-19 Vaccine Breakthrough Infection in Fully Vaccinated Patients with Multiple Comorbid Conditions in the United States |
| title_sort | p13 risk of covid-19 vaccine breakthrough infection in fully vaccinated patients with multiple comorbid conditions in the united states |
| topic | Emerging Evidence on Sars-COV2 Vaccine Utilization and Outcomes |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232695/ http://dx.doi.org/10.1016/j.jval.2022.04.019 |
| work_keys_str_mv | AT lium p13riskofcovid19vaccinebreakthroughinfectioninfullyvaccinatedpatientswithmultiplecomorbidconditionsintheunitedstates AT wongac p13riskofcovid19vaccinebreakthroughinfectioninfullyvaccinatedpatientswithmultiplecomorbidconditionsintheunitedstates AT mcpheetersjt p13riskofcovid19vaccinebreakthroughinfectioninfullyvaccinatedpatientswithmultiplecomorbidconditionsintheunitedstates AT dixonr p13riskofcovid19vaccinebreakthroughinfectioninfullyvaccinatedpatientswithmultiplecomorbidconditionsintheunitedstates AT madgev p13riskofcovid19vaccinebreakthroughinfectioninfullyvaccinatedpatientswithmultiplecomorbidconditionsintheunitedstates AT basrag p13riskofcovid19vaccinebreakthroughinfectioninfullyvaccinatedpatientswithmultiplecomorbidconditionsintheunitedstates AT sachdeva p13riskofcovid19vaccinebreakthroughinfectioninfullyvaccinatedpatientswithmultiplecomorbidconditionsintheunitedstates AT veerankip p13riskofcovid19vaccinebreakthroughinfectioninfullyvaccinatedpatientswithmultiplecomorbidconditionsintheunitedstates |